Introducing multiple vaccines in low- and lower-middle-income countries: issues, opportunities and challenges

Modeling the cost effectiveness of injury interventions in lower and middle income countries: opportunities and challenges

BACKGROUND This paper estimates the cost-effectiveness of five interventions that could counter injuries in lower and middle income countries(LMICs): better traffic enforcement, erecting speed bumps, promoting helmets for bicycles, promoting helmets for motorcycles, and storing kerosene in child proof containers. METHODS We adopt an ingredients based approach to form models of what each inter...

Cancer control opportunities in low- and middle-income countries.

Monitoring and evaluating capacity building activities in low and middle income countries: challenges and opportunities

BACKGROUND Lower and middle income countries (LMICs) are home to >80% of the global population, but mental health researchers and LMIC investigator led publications are concentrated in 10% of LMICs. Increasing research and research outputs, such as in the form of peer reviewed publications, require increased capacity building (CB) opportunities in LMICs. The National Institute of Mental Health ...

Identifying Opportunities and Overcoming Challenges in Conducting Alzheimer’s Disease Trials in Low and Middle Income Countries

Demographic aging is a global phenomenon that demonstrates the success of improved healthcare and better nutrition over the past century. Many are now living longer lives with the result that the world has a growing number of older people. Hand in hand with this “graying” of the population comes an escalation in diseases of aging, most notably Alzheimer’s disease (AD) and related dementias. It ...

Translational Genomics in Low- and Middle-Income Countries: Opportunities and Challenges.

Translation of genomic discoveries into patient care is slowly becoming a reality in developed economies around the world. In contrast, low- and middle-income countries (LMIC) have participated minimally in genomic research for several reasons including the lack of coherent national policies, the limited number of well-trained genomic scientists, poor research infrastructure, and local economic...